Adverse Event for "A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients with N

Project: Research project

Project Details

StatusFinished
Effective start/end date12/3/1512/31/19

Funding

  • PPD Development (Prot # GT-026)
  • Galectin Therapeutics Inc. (Prot # GT-026)